NIH Directors Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)

The NIH Director's Transformative Research Award for Individual and Group Science is a federal funding opportunity administered by the National Institutes of Health through the Office of the Director as part of the Common Fund. This program is a component of the High Risk High Reward Research initiative, which is designed to support exceptionally innovative and unconventional research approaches. The program encourages bold scientific ideas that have the potential to fundamentally alter existing paradigms, create entirely new research directions, or produce transformative advances in biomedical science, clinical practice, or health technologies. It is open to a wide range of scientific domains, including basic, translational, and clinical research, provided that the proposed work demonstrates the potential for broad and significant impact. The primary purpose of this award is to fund research projects that are considered high risk but also high reward. Applicants are not required to provide preliminary data, which distinguishes this opportunity from traditional research grants. Instead, emphasis is placed on the novelty of the concept, the strength of the underlying rationale, and the magnitude of potential impact. The program is structured to support projects that challenge existing scientific assumptions or introduce innovative methodologies, tools, or interventions that could significantly advance knowledge or improve human health outcomes. Funding is provided through the R01 grant mechanism, and projects may span up to five years, allowing investigators sufficient time to pursue ambitious and potentially transformative objectives. Funding for this program is substantial but flexible. The NIH intends to commit approximately eight million dollars in a given fiscal year and expects to fund around seven awards, although the final number depends on the quality and scope of submitted applications. There is no fixed budget cap per project; instead, applicants must propose budgets that are reasonable and aligned with the scale of their research. This flexibility allows for a wide range of project sizes and scopes, from smaller exploratory studies to large, multidisciplinary efforts. There is no cost sharing or matching requirement, reducing financial barriers for applicants. Eligibility for the Transformative Research Award is broad and inclusive. Applicants may include higher education institutions, nonprofit organizations, for profit entities, government agencies at various levels, tribal organizations, and other eligible institutions within the United States. While foreign organizations are not eligible to apply directly, certain forms of international collaboration are permitted, provided they do not involve foreign subawards. Individual investigators with the necessary expertise and institutional support may apply as principal investigators, either independently or as part of a collaborative team. Required registrations include SAM, Grants.gov, and eRA Commons, and all principal investigators must also maintain an ORCID identifier. The application process is conducted electronically through systems such as Grants.gov, ASSIST, or institutional submission platforms. Applicants must adhere strictly to the NIH application guide and specific instructions outlined in the funding announcement. The application emphasizes narrative components such as significance, innovation, impact, and rationale rather than detailed experimental plans. A structured research strategy, timeline, and data management and sharing plan are required. Applications are due by early September, with a strict deadline and no allowance for late submissions. NIH also offers pre application webinars and provides contact support via email for applicant inquiries. Applications undergo a rigorous multi phase peer review process. Reviewers focus heavily on the transformative potential of the proposed research, the strength of the conceptual framework, and the likelihood of achieving significant impact. The review process includes an initial screening, detailed written critiques by expert reviewers, and a final panel discussion for selected applications. Funding decisions are based on scientific merit, alignment with NIH priorities, and availability of funds. Successful applicants can expect project start dates in mid summer of the following year after submission, following advisory council review and final award determinations.

Emphasize transformative potential and innovation over preliminary data; clearly articulate broad impact and novel concepts; align strongly with NIH mission and high risk high reward criteria